James Dalton | |
---|---|
Born | 1963 (age 60–61) |
Academic background | |
Education | BSc., University of Cincinnati PhD., pharmaceutics and pharmaceutical chemistry, Ohio State University |
Thesis | Pharmacokinetic and pharmacodynamic implications of drug absorption from urinary bladder (1990) |
Academic work | |
Institutions | Kettering Medical Center University of Tennessee Ohio State University GTx Incorporated University of Michigan University of Alabama |
James Tilmon Dalton is an American pharmacist and drug discovery scientist. He is Executive Vice President &Provost at the University of Alabama.
As a pharmacy intern and then pharmacist,Dalton worked at Kettering Medical Center. After earning his PhD,Dalton was appointed as assistant professor in the Department of Pharmaceutical Sciences at the University of Tennessee. [1] As a professor at the University of Tennessee,Dalton led the research group that first reported selective androgen receptor modulators (SARMs;enobosarm). In 1997,Dalton’s group published the first report on SARMs,which was used to research and create a class of potential drugs to treat age and disease-related muscle loss. [2] Dalton also led the research group that invented sabizabulin,a tubulin inhibitor under development for the treatment of cancer and SARS-CoV-2 (COVID-19).
From there,he was promoted to associate professor and moved to The Ohio State University (OSU) College of Pharmacy faculty. Dalton was eventually promoted to full professor and Chair of the Division of Pharmaceutics. [1] While at OSU,he was elected a Fellow of the American Association of Pharmaceutical Scientists. [3] The year following his fellowship election,Dalton left OSU to become Chief Scientific Officer at GTx Incorporated. [4] Dalton left GTx in 2014 to become the Dean of Pharmaceutical Sciences at the University of Michigan. [1] The next year,he was elected a fellow of the American Association for the Advancement of Science. [5]
In 2019,Dalton was one of three UMich faculty members elected to National Academy of Medicine. [6]
In 2020,Dalton was appointed Executive Vice President &Provost at the University of Alabama in Tuscaloosa. [7]
Joseph T. DiPiro is professor and Associate Vice President of Health Sciences for Faculty Affairs at Virginia Commonwealth University From 2014 to 2022 he was Dean and Archie O. McCalley Chair,School of Pharmacy.
Dr. William E. Evans,Pharm.D. served as St. Jude Children’s Research Hospital’s fifth director and CEO from 2004 to 2014. From 1986 to 2002,he chaired the St. Jude Department of Pharmaceutical Sciences,and from 2002 to 2004 served as the hospital’s scientific director and executive vice president. He also currently holds the St. Jude Professorship and Endowed chair at the University of Tennessee College of Medicine and Pharmacy.
Krisana Kraisintu is a Thai professor and pharmacist,as known as the "Gypsy pharmacist". She was pharmaceutical consultant in the local production and increased access to life-saving medicines in Africa,in particular,malaria and HIV/AIDS-related drug production.
Michael A. Marletta is an American biochemist. He was born in Rochester,New York,the son of Italian immigrants. He graduated from the State University of New York at Fredonia in 1973 with an A.B. degree in biology and chemistry,and from the University of California,San Francisco in 1978 with a Ph.D. degree in pharmaceutical chemistry,where he studied with George Kenyon. He was a postdoctoral fellow with Christopher T. Walsh at MIT from 1978-1980 and continued as a faculty member at MIT from 1980-1987 whereupon he joined the faculty of the University of Michigan,Ann Arbor. He was John G. Searle Professor of Medicinal Chemistry in the college of pharmacy and professor of biological chemistry at the University of Michigan. In 2001,he moved to the University of California,Berkeley to assume roles as Aldo DeBenedictis Distinguished Professor of Chemistry and professor of biochemistry and molecular biology,and served as the chair of the department of chemistry from 2005 until 2010. He was a Howard Hughes Medical Institute Investigator. From January 2012 to August 2014,Marletta was president and CEO of The Scripps Research Institute in La Jolla,California,succeeding Richard Lerner.
Isa Marte Hussaini is a Nigerian professor of pharmacology and fellow of the Nigerian Academy of Science,inducted into the academy in 2013. He specialized in cancer research and is currently exploring the use of local herbs for cancer therapy. His report to the Nigerian Academy of Science on the use of local herbs for Cancer therapy suggested that herbal plants are more efficacious than the current drugs used in cancer treatments. In May 2015,he presented a paper entitled:“The mining of Nigerian medicinal plants for cancer therapy”in Abuja at the induction of Fellows of the Nigeria Academy of Science where he stated the predictions of the International Agency for Research on Cancer that annual global new cases of cancers are expected to rise from 11 million to 16 million by 2020,with 70 per cent of them coming from developing countries.
Chinedum Peace BabalolaFAS,FAAS is a Nigerian Professor of Pharmaceutical chemistry and Pharmacokinetics. She is a Professor of Pharmacy in the University of Ibadan,FAS,and FAAS. She is the incumbent Vice Chancellor of Chrisland University,Nigeria.
Ahmed Tijjani Mora (OON) is a Nigerian pharmacist,academic,former Registrar and now Chairman of the Governing Council of Pharmacists Council of Nigeria. He is the National President,Ahmadu Bello University Alumni Association. He was elected President of the Alumni Association in August 2015 at the Annual General Assembly (AGA) of the association. The assembly was attended by delegates from over 25 States. Prior to his election,he was the substantive Deputy National president of the association.
Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic,medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University,University of Saugar,and the Panjab University in India,and abroad at the University of Maryland,University of Mississippi and the University of London.
Roger D. Cone is the Mary Sue Coleman Director of the Life Sciences Institute and the Vice Provost for the Biosciences Initiative at the University of Michigan;a member of the editorial board for the journal Cell Metabolism;and a member of the National Academies of Sciences and Medicine. He is a noted researcher in the biological underpinnings of obesity,anorexia,cachexia and other eating and metabolic disorders.
Christopher J. Molloy,PhD,RPh is an American scientist and pharmacist. As of July 1,2021,Dr. Molloy assumed the position of university professor/chancellor emeritus at Rutgers University. He previously served as the chancellor for Rutgers University–New Brunswick Campus (2018-2021). He is an Elected Fellow of the American Association for the Advancement of Science.
James Charles McElnay OBE FCCP FRPharmS is the current Pro-Vice-Chancellor for Research,Enterprise and Postgraduate Affairs and the Acting President and Vice-Chancellor of Queen's University Belfast. He was elected as acting Vice-Chancellor at a meeting of the standing committee of the university following the death of President and Vice-Chancellor Prof. Patrick Johnston. McElnay previously served as acting president and Vice-Chancellor in 2013 before the appointment of Prof. Johnston.
Judith D. Singer is an American academic - statistician and social scientist. She is the James Bryant Conant Professor of Education and Senior Vice Provost for Faculty Development and Diversity at Harvard University.
Christine Allen is a Canadian professor and the first associate vice-president and vice-provost for strategic initiatives at the University of Toronto. She served formerly as interim dean of the university's Leslie Dan Faculty of Pharmacy. She is co-founder of Nanovista,a company focused on imaging of tumors. She also works as the associate editor of Molecular Pharmaceutics.
Rebecca Miriam Cunningham is an American emergency physician and researcher. She is the vice president for research at the University of Michigan,and William G. Barsan Collegiate Professor in the Michigan Medicine Department of Emergency Medicine,and Professor of Health Behavior and Health Education at the School of Public Health. On February 26,2024,she was named the new president of the University of Minnesota.
Charles Okechukwu Esimone is a Nigerian professor of biopharmaceutics and pharmaceutical biotechnology who currently serves as the vice-chancellor of Nnamdi Azikiwe University Awka,Nigeria. He is the first professor of pharmaceutical microbiology in South-Eastern Nigeria.
Fredrick DuBois Bowman is an American statistician who is the Dean of the School of Public Health at the University of Michigan. His research applies statistical analysis to brain imaging to better understand Alzheimer's disease,schizophrenia and Parkinson's disease. Bowman is a member of the National Academy of Medicine,Fellow of the American Association for the Advancement of Science,and Fellow of the American Statistical Association.
Julie Ann Johnson is an American clinical pharmacist and translational scientist. She currently serves as associate dean for clinical and translational research and holds the Dr. Samuel T. and Lois Felts Mercer Professorship of Medicine and Pharmacology at The Ohio State University College of Medicine. She is also be associate vice president for research at Ohio State. Johnson comes to Ohio State from the University of Florida,where she was dean emeritus of pharmacy and a distinguished professor of pharmacy and medicine in the Department of Pharmacotherapy &Translational Research. For four consecutive years,she was a Clarivate Analytics Highly Cited Researcher in Pharmacology and Toxicology,indicating she was one of the "world's leading scholars in the sciences and social sciences in the preceding decade."
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Laurie Kay McCauley is an American dental and medical scholar and academic administrator. She has been serving as the 17th and current provost and executive vice president for academic affairs of the University of Michigan since May 2022.
Melissa Lynn Gilliam is an American pediatric and adolescent gynecologist. She is the first black woman to serve as provost of Ohio State University,having previously served as a Professor of Health Justice at the University of Chicago. On the 4th of October 2023,she was announced as the incoming president of Boston University.